stock-icon

Akums Drugs & Pharmaceuticals Ltd.

AKUMS

604.70
+3.00 (+0.50% ) 1D

Akums Drugs & Pharmaceuticals Ltd. Share Price

604.70 +3.00 (+0.50%)
Full Screen
Akums Drugs & Pharmaceuticals is engaged in contract manufacturing which involves manufacturing of pharmaceutical formulations and specializes in developing new formulations, undertaking bio equivalence studies, clinical trials, obtaining Drug Controller General of India's (DCGI) approval for manufacturing and marketing new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Company's own technology to its customers under their brand names.

Fundamentals

Market Cap

₹9,518Cr

EPS

₹16.67

Book Value/Share

₹210.57

P/E Ratio (TTM)

36.27

Industry P/E (TTM)

40.84

P/B Ratio

3.03

Long Term D/E

0.04

ROE

8.02%

Dividend Yield (TTM)

0.00%

CrispAnalysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Interpretations Icon

Strong Outperformer

Interpretations Icon

Somewhat Undervalued

Interpretations Icon

Good Quality

Interpretations Icon

Low Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Akums Drugs & Pharmaceuticals Ltd.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Mar 2026Q/Q Change
Operating Revenue1,157.87-0.15%
Other Income35.30+2.83%
Total Income1,193.17-0.06%
Total Expenditure1,006.15-0.65%
EBIDT185.23+13.67%
Depreciation40.12+1.19%
Interest23.89+0.63%
Tax39.87+25.02%
Net Profit84.61+27.58%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets3,559.86
Total Non-Current Assets1,887.11
Fixed assets1,631.13
Total Assets5,446.96
Total Current liabilities1,094.76
Total Non Current Liabilities1,021.09
Total Equity Plus Liabilities5,446.96
Total Shareholder Funds3,313.35
Total Debt to Equity2.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity1,181.20
Cash from Financing Activities33.88
Cash from Investing Activities-930.27
Net Cash Flow284.81

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages16

Bearish Moving Averages0

5 Day

603.00

10 Day

593.20

20 Day

563.60

30 Day

551.90

50 Day

545.10

100 Day

507.30

150 Day

482.70

200 Day

477.30

Indicators

Indicators
Technical indicators use historical price and volume data to help predict future price movements.

RSI (14)

65.21

MACD (12, 26)

20.75

MACD Signal Line (9)

16.82

MFI (14)

81.86

ATR (14)

21.92

ADX (14)

27.99

ROC (21)

17.43

ROC (125)

42.94

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic610.00615.30622.25603.05597.75590.80585.50

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

stock-icon

Akums Drugs & Pharmaceuticals Ltd.

AKUMS

604.70
+3.00 (+0.50% ) 1D

Open Price

602.05

Prev Close

601.70

Upper Circuit

665.15

Lower Circuit

544.25

Volume

1,12,143

Average Traded Price

601.49
596.10Today's Low
608.35Today's High
409.3052W Low
635.0052W High

Historical Performance

1 DayNA
5 DaysNA
1 MonthNA
3 MonthsNA
1 YearNA
5 YearsNA
10 YearsNA
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.